Niloofar Rahmani

Array ( [id] => 5398372 [patent_doc_number] => 20090318435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'PYRAZOLOPYRIDINES AND ANALOGS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/480471 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136220 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318435.pdf [firstpage_image] =>[orig_patent_app_number] => 12480471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527843 [patent_doc_number] => 08304413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Compounds and methods for treating inflammatory and fibrotic disorders' [patent_app_type] => utility [patent_app_number] => 12/477715 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61523 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12477715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9575329 [patent_doc_number] => 08765743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 12/994253 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44634 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398479 [patent_doc_number] => 08268859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/477586 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 42170 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12477586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304168 [patent_doc_number] => 20090298820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => '3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES' [patent_app_type] => utility [patent_app_number] => 12/473658 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50366 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298820.pdf [firstpage_image] =>[orig_patent_app_number] => 12473658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320673 [patent_doc_number] => 20100113415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'EPHA4 RTK INHIBITORS FOR TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE DISORDERS AND CANCER' [patent_app_type] => utility [patent_app_number] => 12/473773 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19555 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113415.pdf [firstpage_image] =>[orig_patent_app_number] => 12473773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404583 [patent_doc_number] => 20090239897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/466401 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28537 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239897.pdf [firstpage_image] =>[orig_patent_app_number] => 12466401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539826 [patent_doc_number] => 20090221631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'IMIDAZOPYRIDINONES' [patent_app_type] => utility [patent_app_number] => 12/184494 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17479 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221631.pdf [firstpage_image] =>[orig_patent_app_number] => 12184494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539757 [patent_doc_number] => 20090221562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'NOVEL OPIOID ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/463814 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46831 [patent_no_of_claims] => 160 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221562.pdf [firstpage_image] =>[orig_patent_app_number] => 12463814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071318 [patent_doc_number] => 20110046169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/990760 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89034 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046169.pdf [firstpage_image] =>[orig_patent_app_number] => 12990760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540444 [patent_doc_number] => 08058287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Chemokine receptor antagonists and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 12/436271 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 81 [patent_no_of_words] => 114836 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058287.pdf [firstpage_image] =>[orig_patent_app_number] => 12436271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304409 [patent_doc_number] => 20090299061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'FLUORESCENCE ASSAYS WITH IMPROVED SENSITIVITY' [patent_app_type] => utility [patent_app_number] => 12/426997 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10347 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20090299061.pdf [firstpage_image] =>[orig_patent_app_number] => 12426997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082161 [patent_doc_number] => 08148396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors' [patent_app_type] => utility [patent_app_number] => 12/424674 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20936 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148396.pdf [firstpage_image] =>[orig_patent_app_number] => 12424674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031214 [patent_doc_number] => 20110081409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'SELECTIVE INHIBITORS OF HISTONE DEACETYLASE' [patent_app_type] => utility [patent_app_number] => 12/988271 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 65026 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081409.pdf [firstpage_image] =>[orig_patent_app_number] => 12988271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570348 [patent_doc_number] => 20090253726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'TRI-, TETRA-SUBSTITUTED-3-AMINOPYRROLIDINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/422726 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 60777 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253726.pdf [firstpage_image] =>[orig_patent_app_number] => 12422726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954344 [patent_doc_number] => 20110034506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'TRIAZOLOPYRIDINE COMPOUNDS USEFUL AS DGAT1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/936997 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16242 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034506.pdf [firstpage_image] =>[orig_patent_app_number] => 12936997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703038 [patent_doc_number] => 08088792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/417891 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12543 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088792.pdf [firstpage_image] =>[orig_patent_app_number] => 12417891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534168 [patent_doc_number] => 20090233956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'NOVEL PYRROLO(2,3-b) PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/410135 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 85876 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233956.pdf [firstpage_image] =>[orig_patent_app_number] => 12410135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570357 [patent_doc_number] => 20090253735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => '2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/407449 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9913 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253735.pdf [firstpage_image] =>[orig_patent_app_number] => 12407449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570347 [patent_doc_number] => 20090253725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'ACETYL CoA CARBOXYLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/407694 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 55679 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253725.pdf [firstpage_image] =>[orig_patent_app_number] => 12407694 [rel_patent_id] =>[rel_patent_doc_number] =>)